Top Legislation - View All
Also tagged in: Academic performance, Access to health care, AIDS (Disease), Alcohol and youth, Alcoholism, Ambulatory care, Birth control, Budgets, Business, Child development, Child health, Children, Church and social problems, Citizenship education, Civil rights, Coinsurance, Communications, Community health services, Condoms, Congressional reporting requirements, Consumer discounts, Consumer education, Consumers, Contraceptives, Criminal justice, Data banks, Discrimination in insurance, Discrimination in medical care, Drug abuse, Drugs, Drugs and youth, Education, Elementary and secondary education, Emergency management, Emergency medicine, Employee health benefits, Evaluation research (Social action programs), Families, Federal aid to child health services, Federal aid to health facilities, Federal aid to research, Finance, Government information, Government publicity, Grants-in-aid, Health education, Health information systems, Health insurance, Health policy, Hospital care, Hospitals, Human immunodeficiency viruses, Immigrant health, Immigration, Insurance companies, Labor, Language and languages, Marriage, Medicaid, Medical care, Medical fees, Medical research, Medical statistics, Medically uninsured, Medicine, Nonprofit organizations, Parent and child, Performance measurement, Politics and government, Pregnant women, Prescription pricing, Preventive medicine, Public service advertising, Rape victims, Rebates, Religion, Research grants, School health programs, School-age child care, Science policy, Service learning, Sex, Sex education, Sexual abstinence, Sexually transmitted diseases, Social services, Sociological research, Standards, State and local government, State laws, Technology, Teenage pregnancy, Welfare, Welfare eligibility, Women, Women's health, Women's health services, Youth services
Latest Action: 01/09/2007 - Star Print ordered on the bill. Bill TextA bill to expand access to preventive health care services that help reduce unintended pregnancy, reduce abortions, and improve access to women's health care. 1/4/2007--Introduced. Prevention First Act - Title X Family Planning Services Act of 2007 - Authorizes appropriations for family planning services grants and contracts under the Public Health Service Act (PHSA). Equity in Prescription Insurance and Contraceptive Coverage Act of 2007 - Amends the Employee Retirement Income Security Act of 1974 (ERISA) and PHSA to prohibit a group health plan and a health insurance issuer providing group coverage from excluding or restricting benefits in any way for prescription contraceptive drugs, devices, and outpatient services if the plan or coverage provides benefits for other outpatient prescription drugs, devices, or outpatient services. Applies such prohibitions to coverage offered in the individual market. Emergency Contraception Education Act of 2007 - Directs [...] show full description
Latest Action: 01/04/2007 - Sponsor introductory remarks on measure. (CR S69) Bill TextA bill to amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary. 1/4/2007--Introduced. Generics First Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to exclude from coverage under the Medicare part D prescription drug program all nongeneric (brand name) drugs unless no generic drug has been approved, and the brand name drug is determined to be medically necessary.
Also tagged in: Antitrust law, Business, Competition, Congress, Congressional reporting requirements, Criminal investigation, Criminal justice, Drug industry, Governmental investigations, Intellectual property, Marketing, Medical care, Medicine, Patent infringement, Pharmaceutical research, Restrictive trade practices, Science policy
Latest Action: 03/07/2007 - Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights. Hearings held. Bill TextA bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. 2/27/2007--Reported to Senate without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.) Preserve Access to Affordable Generics Act - Amends the Clayton Act to make it unlawful for a person, in connection with the sale of a drug product, to be a party to any agreement resolving or settling a patent infringement claim in which: (1) an abbreviated new drug (generic) application filer receives anything of value; and (2) such filer agrees not to research, develop, manufacture, market, or sell the generic product for any period. Excludes a resolution or settlement that includes no more than the right to market the generic product prior to the expiration of the patent. Amends the Medicare [...] show full description
Latest Action: 01/30/2007 - Sponsor introductory remarks on measure. (CR S1351-1352) Bill TextA bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs. 1/30/2007--Introduced. Fair Prescription Drug Competition Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the exclusivity period granted to the generic manufacturer.
Also tagged in: Biomedical engineering, Business, Clinical trials, Conflict of interests, Congress, Congressional reporting requirements, Consumers, Corporations, Data banks, Department of Health and Human Services, Drug approvals, Drug industry, Drug interactions, Drug utilization, Drugs, Executive departments, Executive reorganization, Federal advisory bodies, Finance, Financial disclosure, Food and Drug Administration (FDA), Government information, Government paperwork, Government publicity, Health information systems, Labeling, Medical care, Medical instruments and apparatus, Medical supplies, Medical technology, Medicine, Nonprofit organizations, Pharmaceutical research, Politics and government, Product development, Product safety, Research centers, Risk, Science policy, Social services, Technological innovations, Technology
Latest Action: 03/14/2007 - Committee on Health, Education, Labor, and Pensions. Hearings held. Bill TextA bill to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes. 2/1/2007--Introduced. Enhancing Drug Safety and Innovation Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to require an application for approval for a new drug or biological product to include a proposed risk evaluation and mitigation strategy, which must include: (1) labeling for the drug for use by health care providers; (2) submission of reports for the drug; and (3) a statement as to whether the analysis and surveillance are sufficient to assess the serious risks of the drug. Establishes a Drug Safety Oversight Board. Requires the Secretary of Health and Human Services to establish the Reagan-Udall Institute for Applied Biomedical Research as a nonprofit corporation to advance the Critical Path Initiative to modernize medical product development, accelerate innovation, and enhance product [...] show full description
Also tagged in: Access to health care, Business, Developing countries, Drug industry, Drugs, Foreign policy, Free trade, Health policy, Intellectual property, International affairs, Medical care, Medical research, Medicine, Patents, Pharmaceutical research, Research and development, Science policy, Trade, Trade agreements
Latest Action: 07/06/2007 - Referred to the Subcommittee on Trade. Bill TextExpressing the sense of the House of Representatives that the United States should reaffirm the commitments of the United States to the 2001 Doha Declaration on the TRIPS Agreement and Public Health and to pursuing trade policies that promote access to affordable medicines. 6/28/2007--Introduced. Urges the United States to: (1) honor U.S. commitments made in the 2001 World Trade Organization Doha Declaration on the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement and Public Health, which allows World Trade Organization (WTO) members to fully use the flexibilities in the TRIPS Agreement to protect public health and promote access to medicines for all; (2) not place countries on the "Special 301" Priority Watch List for exercising such flexibilites, such as issuing compulsory licenses to obtain generic medicines; (3) not ask developing countries that are trading partners to adopt measures to protect public health intellectual property rights [...] show full description
Also tagged in: Access to health care, Accreditation (Medical care), Advice and consent of the Senate, Aged, Ambulatory care, Appropriations, Bonds, Budgets, Building construction, Capital budgets, Capital investments, Capitation (Medical care), Children, Chiropractic and chiropractors, Civil liberties, Clinics, Coinsurance, Community health services, Compensation (Law), Comprehensive health care, Congress, Congressional reporting requirements, Consumers, Dental care, Dentists, Department of Health and Human Services, Dislocated workers, Drug abuse, Drug abuse treatment, Drugs, Education, Electronic data interchange, Emergency management, Emergency medicine, Excise tax, Executive departments, Executive reorganization, Eye care, Federal aid to child health services, Federal aid to education, Federal-state relations, Finance, Government information, Government paperwork, Government trust funds, Group medical practice, Health counseling, Health education, Health facilities, Health insurance, Health insurance portability, Health maintenance organizations, Health planning, Health policy, Hearing, Hearing aids, Higher education, Home care services, Hospital care, Hospital rates, Hospitals, Identification devices, Income tax, Indian medical care, Indians, Insurance premiums, Investments, Investors, Job hunting, Job training, Labor, Law, Licenses, Long-term care, Long-term care insurance, Managed care, Medicaid, Medical care, Medical economics, Medical education, Medical fees, Medical instruments and apparatus, Medical personnel, Medical records, Medical residents, Medical supplies, Medically uninsured, Medicare, Medicine, Mental health services, Mental illness, Midwives, Minorities, Minority health, National health insurance, Nonprofit organizations, Nurse practitioners, Nursing homes, Occupational retraining, Occupational therapy, Optometry, Osteopathy and osteopaths, Patients' rights, Payroll deductions, Physicians, Physicians' assistants, Poor children, Prescription pricing, Presidential appointments, Presidents, Preventive medicine, Prosthesis, Psychologists, Public health, Quality of care, Right of privacy, Salaries, Social services, State and local government, State laws, Tax rates, Taxation, Technology, Telecommunication, Unemployment insurance, Veterans, Veterans' medical care, Welfare, Withholding tax
Latest Action: 02/02/2007 - Referred to the Subcommittee on Health. Bill TextTo provide for comprehensive health insurance coverage for all United States residents, and for other purposes. 1/24/2007--Introduced. United States National Health Insurance Act (or the Expanded and Improved Medicare for All Act) - Establishes the United States National Health Insurance (USNHI) Program (the Program) to provide all individuals residing in the United States and in U.S. territories with free health care that includes all medically necessary care, such as primary care and prevention, prescription drugs, emergency care, and mental health services. Prohibits an institution from participating in the Program unless it is a public or nonprofit institution. Allows nonprofit health maintenance organizations (HMOs) that actually deliver care in their own facilities to participate in the Program. Gives patients the freedom to choose from participating physicians and institutions. Prohibits a private health insurer from selling health insurance coverage that [...] show full description
Latest Action: 02/05/2007 - Referred to the House Committee on Energy and Commerce. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs. 2/5/2007--Introduced. Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the exclusivity period granted to the generic manufacturer.
Also tagged in: Academic performance, Access to health care, AIDS (Disease), Alcohol and youth, Alcoholism, Ambulatory care, Birth control, Budgets, Business, Child development, Child health, Children, Church and social problems, Citizenship education, Civil rights, Coinsurance, Communications, Community health services, Condoms, Congressional reporting requirements, Consumer discounts, Consumer education, Consumers, Contraceptives, Criminal justice, Data banks, Discrimination in insurance, Discrimination in medical care, Drug abuse, Drugs, Drugs and youth, Education, Elementary and secondary education, Emergency management, Emergency medicine, Employee health benefits, Evaluation research (Social action programs), Families, Federal aid to child health services, Federal aid to health facilities, Federal aid to research, Finance, Government information, Government publicity, Grants-in-aid, Health education, Health information systems, Health insurance, Health policy, Hospital care, Hospitals, Human immunodeficiency viruses, Immigrant health, Immigration, Insurance companies, Labor, Language and languages, Marriage, Medicaid, Medical care, Medical fees, Medical research, Medical statistics, Medically uninsured, Medicine, Nonprofit organizations, Parent and child, Performance measurement, Politics and government, Pregnant women, Prescription pricing, Preventive medicine, Public service advertising, Rape victims, Rebates, Religion, Research grants, School health programs, School-age child care, Science policy, Service learning, Sex, Sex education, Sexual abstinence, Sexually transmitted diseases, Social services, Sociological research, Standards, State and local government, State laws, Technology, Teenage pregnancy, Welfare, Welfare eligibility, Women, Women's health, Women's health services, Youth services
Latest Action: 05/18/2007 - Referred to the Subcommittee on Health, Employment, Labor, and Pensions. Bill TextTo expand access to preventive health care services that help reduce unintended pregnancy, reduce abortions, and improve access to women's health care. 2/5/2007--Introduced. Prevention First Act - Title X Family Planning Services Act of 2007 - Authorizes appropriations for family planning services grants and contracts under the Public Health Service Act (PHSA). Equity in Prescription Insurance and Contraceptive Coverage Act of 2007 - Amends the Employee Retirement Income Security Act of 1974 (ERISA) and PHSA to prohibit a group health plan and a health insurance issuer providing group coverage from excluding or restricting benefits in any way for prescription contraceptive drugs, devices, and outpatient services if the plan or coverage provides benefits for other outpatient prescription drugs, devices, or outpatient services. Applies such prohibitions to coverage offered in the individual market. Emergency Contraception Education Act of 2007 - Directs the Secretary [...] show full description
Also tagged in: Abortion, Actions and defenses, Administrative fees, Administrative procedure, Agriculture, Agriculture in foreign trade, Animals, Antibiotics, Biomedical engineering, Budgets, Business, Canada, Cancer, Chemotherapy, Child health, Children, Clinical trials, Communicable diseases, Communication in medicine, Communications, Conflict of interests, Congress, Congressional investigations, Congressional oversight, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Counterfeiting, Criminal justice, Data banks, Defective products, Department of Health and Human Services, Drug abuse, Drug adulteration, Drug approvals, Drug industry, Drug interactions, Drug law enforcement, Drug therapy, Drug utilization, Drugs, Education, Electronic data interchange, Elementary and secondary education, Environmental protection, Executive departments, Eye diseases, Families, Federal advisory bodies, Federal aid to education, Federal aid to research, Federal reserve system, Fines (Penalties), Food, Food additives, Food and Drug Administration (FDA), Food industry, Food preservation, Food safety, Food supply, Foodborne diseases, Foundations, Fraud, Genetic counseling, Genetic engineering, Genetics, Government information, Government paperwork, Government publicity, Hazardous substances, Health information systems, Health surveys, Health warnings, Higher education, Imaging systems in medicine, Import restrictions, Intellectual property, Internet, Labeling, Law, Marijuana, Meat, Medical care, Medical education, Medical instruments and apparatus, Medical laboratories, Medical records, Medical statistics, Medical supplies, Medicinal plants, Medicine, Orphan drugs, Packaging, Parent and child, Parental consent, Patent infringement, Pediatrics, Pesticides, Pets, Pharmaceutical research, Pharmacists, Physical examinations, Politics and government, Preschool education, Prescription pricing, Prices, Produce trade, Product development, Product safety, Protection of animals, Public meetings, Research and development, Research grants, Restrictive trade practices, Risk, Salmonella, Scholarships, Science policy, Seafood, Shellfish, Skin cancer, Skin diseases, Small business, Social services, Strategic planning, Student loan funds, Technology, Telecommunication, Trade, Turtles, User charges, Web sites
Latest Action: 05/10/2007 - Received in the House. Bill TextAn act to amend the Federal Food, Drug, and cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products, and for other purposes. 5/9/2007--Passed Senate amended. (There are 2 other summaries) Food and Drug Administration Revitalization Act - Title I: Prescription Drug User Fees - (Sec. 101) - Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to set forth as a purpose that authorized prescription drug fees be dedicated toward expediting the drug development process, the process for the review of human drug applications, and postmarket drug safety. Sets forth reporting requirements, including requiring the Secretary of Human Services (the Secretary) to present to Congress recommendations developed for achieving certain goals for the review process of human drug applications and for reauthorization of user [...] show full description
|
Latest Legislation - View All
Also tagged in: Administrative fees, Administrative procedure, Animals, Appropriations, Authorization, Budgets, Business, Congress, Congressional reporting requirements, Department of Health and Human Services, Drug approvals, Drug industry, Electronic government information, Executive departments, Food and Drug Administration (FDA), Government information, Government publicity, Health policy, Law, Medical care, Medicine, Pharmaceutical research, Science policy, Sunset legislation, Technology, Telecommunication, Veterinary medicine
Latest Action: 07/30/2008 - Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 110-805. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to establish a program of fees relating to generic new animal drugs. 7/30/2008--Reported to House amended. (There is 1 other summary) Animal Generic Drug User Fee Act of 2008 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to assess and collect fees for an abbreviated application for a generic new animal drug, including application fees, product fees, and sponsor fees.Sets forth total revenue to be collected for each type of fee for FY2009-FY2013.Provides for fee adjustments. Requires the Secretary to establish such fees each fiscal year.Provides for fee waivers where the Secretary finds that the generic new animal drug is intended solely to provide for a minor use or minor species indication.Authorizes appropriations for FY2009-FY2013.Requires the Secretary to report to Congress and make publicly available information [...] show full description
Also tagged in: Administrative fees, Administrative remedies, Agriculture, Animals, Antibiotics, Budgets, Civil liberties, Clinical trials, Congress, Congressional reporting requirements, Consumers, Data banks, Drug approvals, Drug resistance in microorganisms, Drugs, Food, Food safety, Government information, Government publicity, Law, Livestock, Meat, Medical care, Medicine, Right of petition, Technology, User charges, Veterinary medicine
Latest Action: 08/14/2008 - Signed by President. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to revise and extend the animal drug user fee program, to establish a program of fees relating to generic new animal drugs, to make certain technical corrections to the Food and Drug Administration Amendments Act of 2007, and for other purposes. 8/14/2008--Public Law. (There are 3 other summaries) (This measure has not been amended since it was passed by the House on July 30, 2008. The summary of that version is repeated here.) Title I: Animal Drug User Fee Amendments - Animal Drug User Fee Amendments of 2008 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act to revise definitions, including defining the "process for the review of animal drug applications" to include the review of advertising and labeling prior to an approval of an animal drug application or supplemental animal application after the animal drug has been approved.(Sec. 103) Requires the [...] show full description
Also tagged in: Actions and defenses, Administrative procedure, Administrative remedies, Admission of nonimmigrants, Afghanistan, Air force, Air piracy, Airports, Alaska, Alien labor, Alien property, Ammunition, Anniversaries, Annuities, Appellate procedure, Armed forces, Armed forces abroad, Armed forces reserves, Arms control, Arms sales, Army, Art, Auditing, Authorization, Ballistic missile defenses, Ballistic missiles, Blind, Budgets, Business, Business records, Buy American, Capital investments, Chemical warfare, Children, Civil service retirement, Civil war, Clothing, Coast guard, Coinsurance, Cold War, Collection of accounts, College costs, College teachers, Colorado, Commemorations, Commercial blacklisting, Compensation (Law), Competition, Competitive bidding, Congress, Congress and military policy, Congressional investigations, Congressional oversight, Congressional reporting requirements, Congressional tributes, Cost accounting, Courts of special jurisdiction, Criminal justice, Damages, Defense budgets, Defense contracts, Defense economics, Defense industries, Defense policy, Defense procurement, Dentists, Department of Defense, Disability evaluation, Disabled, District of Columbia, Drug abuse, Drug law enforcement, Drugs, East Asia, Education, Electronic government information, Elementary and secondary education, Employee training, Energy, Environmental protection, Europe, Executive departments, Executive reorganization, Families, Family violence, Federal advisory bodies, Federal employees, Fighter aircraft, Finance, Fines (Penalties), Firearms, Foreign corporations, Foreign policy, Free trade, Fringe benefits, Garnishment, Gifts, Government contractors, Government employees, Government employees' health insurance, Government information, Government liability (International law), Government paperwork, Government publicity, Governmental investigations, Hawaiians, Hazardous substances, Hazardous waste sites, Hazardous wastes, Health insurance, Health policy, Higher education, History, Hostages, Housing, Humanities, Immigrants, Immigration, Impact aid, Indigenous peoples, Information technology, Inspectors general, Insurance premiums, Intellectual property, International affairs, International agencies, International claims, International finance, Iran, Iraq, Iraq compilation, Israel, Job training, Joint ventures, Jurisdiction, Korean War, 1950-1953, Labor, Laboratories, Law, Leases, Legal aid, Liability for environmental damages, Licenses, Liens, Logistics, Managed care, Marines, Married people, Maryland, Medical care, Medical economics, Medical personnel, Medical tests, Medicine, Mental health services, Mentoring, Metals, Middle East and North Africa, Military agreements, Military aircraft, Military and naval supplies, Military base closures, Military cemeteries and funerals, Military civic action, Military dependents, Military discharges, Military education, Military helicopters, Military housing, Military medals, decorations, etc., Military medicine, Military occupation, Military operations, Military pay, Military pensions, Military personnel, Military promotions, Military readiness, Military research, Military training, Military transportation, Military vehicles, Minorities, Minority business enterprises, Minority education, Missile warheads, Monuments and memorials, Motor vehicles, Murder, Music, National Guard, Natural resources, Naturalization, Navy, New York State, Nuclear nonproliferation, Nurse practitioners, Nursing education, Officer personnel, Olympic games, Ordnance, Paralysis, Parties to actions, Pensions, Petroleum reserves, Physicians, Politics and government, Post exchanges, Prescription pricing, Privatization, Psychiatrists, Psychologists, Public contracts, Public-private partnerships, Recruiting and enlistment, Refugees, Relocation, Reprogramming of appropriated funds, Rescue work, Research and development, Research and development facilities, Research centers, Residence requirements, Retired military personnel, Sabotage, Salaries, Sanctions (International law), Scholarships, Science policy, Searches and seizures, Sheltered workshops, Shipbuilding, Shipyards, Small business, Soldiers' homes, Solid wastes, Sound recording and reproducing, South Asia, State-sponsored terrorism, Strategic materials, Student loan funds, Subcontractors, Submarines, Subsidies, Surface-to-air missiles, Survivors' benefits, Syria, Tanks (Combat vehicles), Teachers, Technology, Technology assessment, Technology transfer, Telecommunication, Terrorism, Torture, Toys, Trade, Trade agreements, Trademarks, Transport aircraft, Transportation, Travel costs, Veterans, Veterans' benefits, Veterans' disability compensation, Veterans' education, Veterans' medical care, Victims of terrorism, Vietnam veterans, Vietnamese Conflict, Virginia, Visas, Warships, Washington State, Weapons systems, World War II
Latest Action: 01/28/2008 - Signed by President. Bill TextTo provide for the enactment of the National Defense Authorization Act for Fiscal Year 2008, as previously enrolled, with certain modifications to address the foreign sovereign immunities provisions of title 28, United States Code, with respect to the attachment of property in certain judgements against Iraq, the lapse of statutory authorities for the payment of bonuses, special pays, and similar benefits for members of the uniformed services, and for other purposes. 1/28/2008--Public Law. (There are 2 other summaries) (This measure has not been amended since it was passed by the House on January 16, 2008. The summary of that version is repeated here.) National Defense Authorization Act for Fiscal Year 2008 - Division A: Department of Defense Authorizations - Title I: Procurement - Subtitle A: Authorization of Appropriations - (Sec. 101) Authorizes appropriations for FY2008 for the Army, Navy and Marine Corps, and Air Force for [...] show full description
Also tagged in: Access to health care, Administrative fees, Administrative procedure, Administrative remedies, Agriculture, Animals, Antibiotics, Aquaculture, Authorization, Authors and authorship, Budgets, Business, Child health, Children, Civil liberties, Clinical trials, Communicable diseases, Communication in medicine, Communication in science, Communications, Conflict of interests, Congress, Congressional investigations, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Criminal justice, Criminal justice information, Data banks, Deceptive advertising, Department of Health and Human Services, Direct mail advertising, Directories, Drug advertising, Drug approvals, Drug industry, Drug resistance in microorganisms, Drugs, Electronic data interchange, Electronic government information, Emergency communication systems, Emergency management, Employee training, Environmental assessment, Environmental protection, Executive departments, Executive reorganization, Eye diseases, Federal advisory bodies, Federal employees, Federal officials, Federal preemption, Financial disclosure, Fines (Penalties), Food and Drug Administration (FDA), Food labeling, Food safety, Foundations, Fund raising, Genetic engineering, Genetic research, Gifts, Government employees, Government information, Government paperwork, Government publicity, Grants-in-aid, Hazardous substances, Health information systems, Health policy, Health surveys, Humanities, Identification devices, Imports, Intellectual property, Internet, Inventors, Job training, Labeling, Law, Local laws, Medical associations, Medical care, Medical ethics, Medical instruments and apparatus, Medical supplies, Medicine, Nonprofit organizations, Nosocomial infections, Orphan drugs, Patents, Pediatrics, Peer review organizations (Medicine), Performance measurement, Pesticides, Pharmaceutical research, Physicians, Product counterfeiting, Product development, Product safety, Public contracts, Public meetings, Public-private partnerships, Radioisotopes in medicine, Research and development, Research grants, Right of privacy, Risk, Science policy, Scientists in government, Seafood, Skin cancer, Small business, Social services, Standards, State and local government, State laws, Technology, Telecommunication, Television advertising, Terrorism, Trade, Trade agreements, Trade negotiations, User charges, Veterinary medicine, Warning labels
Latest Action: 09/27/2007 - Signed by President. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. 9/27/2007--Public Law. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)Food and Drug Administration Amendments Act of 2007 - Title I: Prescription Drug User Fee Amendments of 2007 - (Sec. 101) Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to include postmarket safety activities within the process for the review of human drug applications or supplements, including: (1) developing and using improved adverse event data collection systems and improved analytical tools to assess potential [...] show full description
Also tagged in: Budgets, Congress, Congressional investigations, Congressional reporting requirements, Cost accounting, Drugs, Health policy, Medicaid, Medical care, Medicine, Pharmacies, Prescription pricing, Welfare
Latest Action: 07/24/2007 - Referred to the House Committee on Energy and Commerce. Bill TextTo amend title XIX of the Social Security Act to ensure and foster continued beneficiary access to generic drugs under the Medicaid Program by setting pharmacy reimbursement based on retail acquisition cost and to promote the use of generic drugs. 7/24/2007--Introduced. Saving Our Community Pharmacies Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to provide for: (1) use of median retail acquisition cost as the basis for Medicaid reimbursement limits on generic drugs; and (2) establishment of an evidence-based prescription drug program. Directs the Comptroller General to study and report to Congress on the costs of community retail pharmacies to dispense prescription drugs.
Also tagged in: Abortion, Access to health care, Actions and defenses, Administrative procedure, Aged, Ambulances, Ambulatory care, Auditing, Birth control, Bonds, Breast cancer, Budgets, Business, Capital budgets, Capitation (Medical care), Case management, Charitable contributions, Child health, Childbirth, Children, Chronically ill, Civil liberties, Civil rights, Civil service retirement, Clinical trials, Collection of accounts, Collective bargaining, Communication in medicine, Communications, Community health services, Comprehensive health care, Conflict of interests, Congressional reporting requirements, Consumer complaints, Consumers, Continuing education, Corporation taxes, Curricula, Day care, Dental care, Department of Health and Human Services, Disabled, Disasters, Discrimination in medical care, Drugs, Education, Emergency management, Emergency medicine, Eminent domain, Employee health benefits, Employee rights, Employee selection, Employee training, Employment tests, Environmental health, Environmental monitoring, Environmental protection, Environmentally induced diseases, Epidemics, Epidemiology, Executive departments, Executive reorganization, Eye care, Eyeglasses, Families, Federal aid to education, Federal employees, Federal preemption, Financial statements, Geriatrics, Government employees, Government information, Government paperwork, Government publications, Government publicity, Government trust funds, Grievance procedures, |
